Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement

Journal of the American College of Cardiology

Volumn 64, Issue 2, 2014, Pages 144-154

  Barone Rochette, Gilles ^a   Piérard, Sophie ^a   De Meester De Ravenstein, Christophe ^a   Seldrum, Stéphanie ^a   Melchior, Julie ^a   Maes, Frédéric ^a   Pouleur, Anne Catherine ^a   Vancraeynest, David ^a   Pasquet, Agnes ^a   Vanoverschelde, Jean Louis ^a   Gerber, Bernhard L ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

aortic stenosis; aortic valve replacement; late gadolinium enhanced cardiac magnetic resonance

Indexed keywords

GADOLINIUM;

AGED; ANGIOCARDIOGRAPHY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; COMORBIDITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE FIBROSIS; HIGH RISK PATIENT; HUMAN; LATE GADOLINIUM ENHANCEMENT; LONG TERM SURVIVAL; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; POST TREATMENT SURVIVAL; PREDICTOR VARIABLE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL PREDICTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

AORTIC STENOSIS; AORTIC VALVE REPLACEMENT; LATE GADOLINIUM ENHANCED CARDIAC MAGNETIC RESONANCE;

AGED; AORTIC VALVE STENOSIS; BELGIUM; CARDIAC CATHETERIZATION; CAUSE OF DEATH; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84903995942     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.02.612     Document Type: Article

References (33)

1. B. Iung, G. Baron, and E.G. Butchart et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243
2. S. Hein, E. Arnon, and S. Kostin et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms Circulation 107 2003 984 991
3. S. Heymans, B. Schroen, and P. Vermeersch et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart Circulation 112 2005 1136 1144
4. F. Weidemann, S. Herrmann, and S. Stork et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis Circulation 120 2009 577 584
5. M. Nigri, C.F. Azevedo, and C.E. Rochitte et al. Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: correlation with quantitative histopathology Am Heart J 157 2009 361 368
6. M.R. Dweck, N.A. Boon, and D.E. Newby Calcific aortic stenosis: a disease of the valve and the myocardium J Am Coll Cardiol 60 2012 1854 1863
7. O. Lund, L.H. Kristensen, and U. Baandrup et al. Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis Eur Heart J 19 1998 1099 1108
8. S. Herrmann, S. Stork, and M. Niemann et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome J Am Coll Cardiol 58 2011 402 412
9. N. Mewton, C.Y. Liu, and P. Croisille et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
10. C.F. Azevedo, M. Nigri, and M.L. Higuchi et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease J Am Coll Cardiol 56 2010 278 287
11. A. Rudolph, H. Abdel-Aty, and S. Bohl et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling J Am Coll Cardiol 53 2009 284 291
12. M.R. Dweck, S. Joshi, and T. Murigu et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis J Am Coll Cardiol 58 2011 1271 1279
13. E. Heiberg, J. Sjogren, and M. Ugander et al. Design and validation of Segment - freely available software for cardiovascular image analysis BMC Med Imaging 10 2010 1
14. E. Heiberg, M. Ugander, and H. Engblom et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study Radiology 246 2008 581 588
15. A. Vahanian, O. Alfieri, and F. Andreotti et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg 42 2012 S1 44
16. H.P. Krayenbuehl, O.M. Hess, and E.S. Monrad et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement Circulation 79 1989 744 755
17. J. Fielitz, S. Hein, and V. Mitrovic et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease J Am Coll Cardiol 37 2001 1443 1449
18. D. Garcia, P.G. Camici, and L.G. Durand et al. Impairment of coronary flow reserve in aortic stenosis J Appl Physiol 106 2009 113 121
19. C.D. Steadman, M. Jerosch-Herold, and B. Grundy et al. Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis J Am Coll Cardiol Img 5 2012 182 189
20. A.D. Milano, G. Faggian, and M. Dodonov et al. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis J Thorac Cardiovasc Surg 144 2012 830 837
21. C. Quarto, M.R. Dweck, and T. Murigu et al. Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement Interact Cardiovasc Thorac Surg 15 2012 45 50
22. R.Y. Kwong, H. Sattar, and H. Wu et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction Circulation 118 2008 1011 1020
23. R.G. Assomull, S.K. Prasad, and J. Lyne et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
24. A. Gulati, A. Jabbour, and T.F. Ismail et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy JAMA 309 2013 896 908
25. O. Bruder, A. Wagner, and C.J. Jensen et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
26. R. O'Hanlon, A. Grasso, and M. Roughton et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
27. P.A. Scott, J.M. Morgan, and N. Carroll et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators Circ Arrhythm Electrophysiol 4 2011 324 330
28. P. Gao, R. Yee, and L. Gula et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging Circ Cardiovasc Imaging 5 2012 448 456
29. C.M. Otto Valvular aortic stenosis: disease severity and timing of intervention J Am Coll Cardiol 47 2006 2141 2151
30. A. Vahanian, O. Alfieri, and F. Andreotti et al. Guidelines on the management of valvular heart disease (version 2012) Eur Heart J. 33 2012 2451 2496
31. R.A. Nishimura, C.M. Otto, and R.O. Bonow et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 e57 e185
32. A.S. Flett, M.P. Hayward, and M.T. Ashworth et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
33. J.L. Monin, P. Lancellotti, and M. Monchi et al. Risk score for predicting outcome in patients with asymptomatic aortic stenosis Circulation 120 2009 69 75